Results 111 to 120 of about 1,931,799 (309)
INCIDENCE OF ECTOPIC PREGNANCY DURING THE PHASE III CLINICAL TRIALS FOR DROSPIRENONE 4mg AS AN ORAL CONTRACEPTIVE [PDF]
, 2023 Megan L. Gilbert +2 more
openalex +1 more source
The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes
Clinical Pharmacology &Therapeutics, EarlyView.Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali +4 more
wiley +1 more source
Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate [PDF]
, 2001 Marcos Perrotti +3 more
openalex +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Baloxavir acid (baloxavir), the active metabolite of the prodrug baloxavir marboxil, is a selective inhibitor of the influenza virus cap‐dependent endonuclease. The population pharmacokinetic (popPK) profile of baloxavir in adults/adolescents has been described previously.
Sylvie Retout +6 more
wiley +1 more source
Oral Contraceptives and HRT Risk of Thrombosis
Clinical and applied thrombosis/hemostasis, 2018 A. Gialeraki +4 more
semanticscholar +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source
Routine control of oral contraceptive users: a new ‘standard’ in The Netherlands
, 1992 Chris van Weel
openalex +2 more sources
Oral contraceptives and risk of gallbladder disease [PDF]
, 2011 Mahyar Etminan
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source